Art. -Nr.: HY-Y0445A

Sodium dichloroacetate

28 Cited Publications

Kundenbewertung

Based on 28 publication(s) in Google Scholar

Sodium dichloroacetate is an orally active pyruvate dehydrogenase kinase (PDK) inhibitor. Sodium dichloroacetate also stimulates pyruvate dehydrogenase (PDH) activity and works as a Na⁺-K⁺-2Cl⁻ cotransporter (NKCC) inhibitor. Sodium dichloroacetate prevents the phosphorylation of the E1α subunit of PDC, promoting the entry of pyruvate into the mitochondria for oxidative metabolism, reducing lactate production, and simultaneously increasing the production of reactive oxygen species (ROS). Sodium dichloroacetate inhibits tumor cell proliferation and induces apoptosis. Sodium dichloroacetate is promising for research of cancers.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

Reinheit: 99.78%
CAS. Nr.: 2156-56-1
Formel: C₂HCl₂NaO₂
Molecular Weight:150.92

Speicherung:

4°C, sealed storage, away from moisture

* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

Sodium dichloroacetate Chemical Structure

CAS. Nr.: 2156-56-1

Größe

Preis

Verfügbarkeit

Menge

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- IC₅₀ & Target
- Cellular Effect
- In Vitro
- In Vivo
- Clinical Trial
Chemical Information
Publications (28)
Lösungsmittel & Löslichkeit
- In Vitro
- In Vivo
Reinheit & Dokumentation
Verweise
Help & FAQs
Bioz

Biologische Aktivität

Beschreibung

IC₅₀ & Target

PDHK; Reactive oxygen species (ROS); Apoptosis; NKCC^[1]

Cellular Effect

Cell Line	Type	Value	Description	References
4T1	IC₅₀	>100 μM Compound: Na-DCA	Anticancer activity against mouse 4T1 cells expressing PDK assessed as reduction in cell viability after 72 hrs by MTT assay Anticancer activity against mouse 4T1 cells expressing PDK assessed as reduction in cell viability after 72 hrs by MTT assay	[PMID: 31509699]
A-375	IC₅₀	>100 μM Compound: Na-DCA	Anticancer activity against human A375 cells expressing PDK assessed as reduction in cell viability after 72 hrs by MTT assay Anticancer activity against human A375 cells expressing PDK assessed as reduction in cell viability after 72 hrs by MTT assay	[PMID: 31509699]
A-375	IC₅₀	20.1 mM Compound: DCA	Antiproliferative activity against human A375 cells assessed as growth inhibition after 72 hrs by MTT assay Antiproliferative activity against human A375 cells assessed as growth inhibition after 72 hrs by MTT assay	[PMID: 33550182]
A549	IC₅₀	1011 μM Compound: DCA	Anticancer activity against human A549 cells after 72 hrs by MTT assay Anticancer activity against human A549 cells after 72 hrs by MTT assay	[PMID: 20663593]
A549	IC₅₀	19.5 mM Compound: DCA	Antiproliferative activity against human A549 cells assessed as growth inhibition after 72 hrs by MTT assay Antiproliferative activity against human A549 cells assessed as growth inhibition after 72 hrs by MTT assay	[PMID: 33550182]
A549	IC₅₀	20.1 mM Compound: DCA	Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 72 hrs by MTT assay Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 72 hrs by MTT assay	[PMID: 30470491]
A549	IC₅₀	23.58 mM Compound: DCA	Cytotoxicity against human A549 cells assessed as growth inhibition after 72 hrs by MTT assay Cytotoxicity against human A549 cells assessed as growth inhibition after 72 hrs by MTT assay	[PMID: 27006991]
A549	IC₅₀	4286 μM Compound: DCA	Cytotoxicity against human A549 cells after 68 hrs by MTT assay Cytotoxicity against human A549 cells after 68 hrs by MTT assay	[PMID: 23067553]
Bel-7402	IC₅₀	860 μM Compound: DCA	Anticancer activity against human Bel7402 cells after 72 hrs by MTT assay Anticancer activity against human Bel7402 cells after 72 hrs by MTT assay	[PMID: 20663593]
BGC-823	IC₅₀	1051 μM Compound: DCA	Anticancer activity against human BGC823 cells after 72 hrs by MTT assay Anticancer activity against human BGC823 cells after 72 hrs by MTT assay	[PMID: 20663593]
CCD-841CoN	IC₅₀	12.5 μM Compound: SDA	Cytotoxicity against human CRL1790 cells assessed as inhibition of cell growth Cytotoxicity against human CRL1790 cells assessed as inhibition of cell growth	[PMID: 31864797]
HCT-116	IC₅₀	>100 μM Compound: Na-DCA	Anticancer activity against human HCT116 cells expressing PDK assessed as reduction in cell viability after 72 hrs by MTT assay Anticancer activity against human HCT116 cells expressing PDK assessed as reduction in cell viability after 72 hrs by MTT assay	[PMID: 31509699]
HCT-116	IC₅₀	14.8 μM Compound: SDA	Cytotoxicity against human HCT116 cells assessed as inhibition of cell growth Cytotoxicity against human HCT116 cells assessed as inhibition of cell growth	[PMID: 31864797]
HCT-116	IC₅₀	9.8 mM Compound: DCA	Antiproliferative activity against human HCT-116 cells assessed as growth inhibition after 72 hrs by MTT assay Antiproliferative activity against human HCT-116 cells assessed as growth inhibition after 72 hrs by MTT assay	[PMID: 33550182]
KB	IC₅₀	1424 μM Compound: DCA	Anticancer activity against human KB cells after 72 hrs by MTT assay Anticancer activity against human KB cells after 72 hrs by MTT assay	[PMID: 20663593]
KB 3-1	IC₅₀	5883 μM Compound: DCA	Cytotoxicity against human KB-3-1 cells after 68 hrs by MTT assay Cytotoxicity against human KB-3-1 cells after 68 hrs by MTT assay	[PMID: 23067553]
L02	IC₅₀	>100 μM Compound: Na-DCA	Cytotoxicity against human LO2 cells assessed as reduction in cell viability after 72 hrs by MTT assay Cytotoxicity against human LO2 cells assessed as reduction in cell viability after 72 hrs by MTT assay	[PMID: 31509699]
L02	IC₅₀	21.7 mM Compound: DCA	Cytotoxicity against human L02 cells assessed as reduction in cell viability after 72 hrs by MTT assay Cytotoxicity against human L02 cells assessed as reduction in cell viability after 72 hrs by MTT assay	[PMID: 33550182]
MCF7	IC₅₀	>100 μM Compound: Na-DCA	Anticancer activity against human MCF7 cells overexpressing PDK assessed as reduction in cell viability after 72 hrs by MTT assay Anticancer activity against human MCF7 cells overexpressing PDK assessed as reduction in cell viability after 72 hrs by MTT assay	[PMID: 31509699]
MCF7	IC₅₀	12.35 mM Compound: DCA	Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by MTT assay Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by MTT assay	[PMID: 27006991]
MCF7	IC₅₀	13.4 mM Compound: DCA	Antiproliferative activity against human MCF7 cells assessed as growth inhibition after 72 hrs by MTT assay Antiproliferative activity against human MCF7 cells assessed as growth inhibition after 72 hrs by MTT assay	[PMID: 33550182]
NCI-H1650	IC₅₀	16.3 mM Compound: DCA	Antiproliferative activity against human NCI-H1650 cells assessed as reduction in cell viability after 72 hrs by MTT assay Antiproliferative activity against human NCI-H1650 cells assessed as reduction in cell viability after 72 hrs by MTT assay	[PMID: 30470491]
NCI-H460	IC₅₀	3892 μM Compound: DCA	Cytotoxicity against human H460 cells after 68 hrs by MTT assay Cytotoxicity against human H460 cells after 68 hrs by MTT assay	[PMID: 23067553]
PC-3	IC₅₀	15.7 mM Compound: DCA	Antiproliferative activity against human PC3 cells assessed as growth inhibition after 72 hrs by MTT assay Antiproliferative activity against human PC3 cells assessed as growth inhibition after 72 hrs by MTT assay	[PMID: 33550182]
SH-SY5Y	IC₅₀	17.4 mM Compound: DCA	Antiproliferative activity against human SHSY-5Y cells assessed as growth inhibition after 72 hrs by MTT assay Antiproliferative activity against human SHSY-5Y cells assessed as growth inhibition after 72 hrs by MTT assay	[PMID: 33550182]

In Vitro

Sodium dichloroacetate increases ROS generation in mitochondria. Sodium dichloroacetate affects cell growth and viability through the ROS production increase derived from the promotion of oxidative metabolism. The effects of Sodium dichloroacetate on multiple myeloma cell viability, cell cycle arrest, and apoptotic cell death were associated with pyruvate dehydrogenase kinases (PDK) inhibition, restored pyruvate dehydrogenase (PDH) activity, and the promotion of oxidative metabolism in association with increased intracellular ROS production which depends on the Sodium dichloroacetate dose. The Sodium dichloroacetate effects cooperated with C I inhibition promoting the oxidative stress in rat VM-M3 glioblastoma cells. Increased ROS levels in Sodium dichloroacetate-treated cancer cells are related to the induction of apoptosis associated with the increased cytochrome c expression. Sodium dichloroacetate causes ROS-dependent T-cell differentiation^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

The NKCC1 RNA expression levels in Sodium dichloroacetate-treated gonad-intact and castrated males are significantly decreased, and no such effect is determined in the gonad-intact and castrated female Sodium dichloroacetate-treated rats^[1].
A single Sodium dichloroacetate dose causes a significantly higher 24 h diuresis in Wistar male rats, and the increased diuresis is related to NKCC2 inhibition. The NKCC2 is more abundant in kidneys of intact females compared to intact males, with a greater transporter density in Sprague-Dawley female rats^[1].
The oral Sodium dichloroacetate bioavailability in na ve male rats dosed 5, 20 and 100 mg/kg is significantly lower than in GSTζ-depleted ones (10%, 13%, 81% and 31%, 75%, 100%, respectively). The liver extraction of Sodium dichloroacetate in the GSTζ-depleted rats has linear kinetics, but it decreases with the metabolism saturation at higher doses^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Clinical Trial

NCT Number	Sponsor	Condition	Start Date	Phase A549
NCT01329991	Plexxikon\|		2011-05	PHASE1

Chemical Information

CAS. Nr. 2156-56-1
Appearance Solid
Molecular Weight 150.92
Formel C₂HCl₂NaO₂
Color White to off-white
SMILES

O=C(O[Na])C(Cl)Cl
Versand

Room temperature in continental US; may vary elsewhere.
Speicherung

4°C, sealed storage, away from moisture

* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

Publications (28)

All WBIFIn Vivo Efficacy StudyCell Proliferation/Viability Assay

Sort by:

Journal Impact Factor

Signal Transduct Target Ther

Suppression of PFKFB3-driven glycolysis restrains endothelial-to-mesenchymal transition and fibrotic response. [Abstract]

2022 Sep 1;7(1):303. PMID: 36045132
Cell Death Differ

Tufm lactylation regulates neuronal apoptosis by modulating mitophagy in traumatic brain injury. [Abstract]

2025 Mar;32(3):530-545. PMID: 39496783
Adv Sci (Weinh)

Acidosis Forces Fatty Acid Uptake and Metabolism in Cancer Cells Regardless of Genotype. [Abstract]

2025 Jul 29:e05436. PMID: 40726407
Adv Sci (Weinh)

UGDH Lactylation Aggravates Osteoarthritis by Suppressing Glycosaminoglycan Synthesis and Orchestrating Nucleocytoplasmic Transport to Activate MAPK Signaling. [Abstract]

2025 Mar 27:e2413709. PMID: 40150862
Redox Biol

Histone lactylation drives liver cancer metastasis by facilitating NSF1-mediated ferroptosis resistance after microwave ablation. [Abstract]

2025 Apr:81:103553. PMID: 39970777
Cell Death Dis

Pyruvate dehydrogenase kinase 1 protects against neuronal injury and memory loss in mouse models of diabetes. [Abstract]

2023 Nov 7;14(11):722. PMID: 37935660
Cell Death Dis

Mitochondrial dysfunction induces radioresistance in colorectal cancer by activating [Ca2+]m-PDP1-PDH-histone acetylation retrograde signaling. [Abstract]

2021 Sep 6;12(9):837. PMID: 34489398

Sodium dichloroacetate purchased from MedChemExpress. Usage Cited in: Cell Death Dis. 2021 Sep 6;12(9):837. [Abstract]

Western blot analysis of PDH, H3K9ac, H3K56ac, and DNA repair proteins in NC cells and ROT cells with or without DCA (5 mM) for 6 h and 24 h in the ROT group.
Proc Natl Acad Sci U S A

Dynamic investigation of hypoxia-induced L-lactylation. [Abstract]

2025 Mar 11;122(10):e2404899122. PMID: 40030031
J Autoimmun

Neutrophil extracellular traps induce trophoblasts pyroptosis via enhancing NLRP3 lactylation in SLE pregnancies. [Abstract]

2025 Apr 2:153:103411. PMID: 40179478
Fundam Res

Astrocytic pyruvate dehydrogenase kinase-lactic acid axis involvement in glia-neuron crosstalk contributes to morphine-induced hyperalgesia in mice. [Abstract]

2023 Mar 6;4(4):820-828. PMID: 39161415

Sodium dichloroacetate purchased from MedChemExpress. Usage Cited in: Fundam Res. 2023 Mar 6;4(4):820-828. [Abstract]

The PDK4 inhibitor DCA was diluted with saline to a concentration of 20 mg/ml, and injected intrathecally (i.t., 10 μl) 30 min before morphine. Immunostaining analysis of the activity of GFAP in SDHs was performed.

Sodium dichloroacetate purchased from MedChemExpress. Usage Cited in: Fundam Res. 2023 Mar 6;4(4):820-828. [Abstract]

The PDK4 inhibitor DCA was diluted with saline to a concentration of 20 mg/ml, and injected intrathecally (i.t., 10 μl) 30 min before morphine. Protein levels of PDK4, p-S²⁹³-PDH, and p-S³⁰⁰-PDH in SDHs were measured.

Sodium dichloroacetate purchased from MedChemExpress. Usage Cited in: Fundam Res. 2023 Mar 6;4(4):820-828. [Abstract]

The PDK4 inhibitor DCA was diluted with saline to a concentration of 20 mg/ml and injected intrathecally (i.t., 10 μl) 30 min before morphine. The accumulation of lactate in SDHs was detected with the lactate assay; n = 4
Cell Mol Life Sci

The transcription factor RBPJ is required for inflammatory macrophage activation in thoracic aortic dissection by mediating mechanotransduction-induced glycolysis. [Abstract]

2025 Oct 28;82(1):370. PMID: 41148245
Biochem Pharmacol

Dihydroartemisinin breaks the positive feedback loop of YAP1 and GLUT1-mediated aerobic glycolysis to boost the CD8+ effector T cells in hepatocellular carcinoma. [Abstract]

2024 May 14:225:116294. PMID: 38754557
J Ethnopharmacol

Exploration of the underlying mechanism of Astragaloside III in attenuating immunosuppression via network pharmacology and vitro/vivo pharmacological validation. [Abstract]

2024 Aug 10:330:118235. PMID: 38648891
Cancer Drug Resist

Dichloroacetate enhances the antitumor effect of pirarubicin via regulating the ROS-JNK signaling pathway in liver cancer cells. [Abstract]

2020 Sep 4;3(4):947-958. PMID: 35582217
Life Sci

SIRT6 inhibits hypoxia-induced pulmonary arterial smooth muscle cells proliferation via HIF-1α/PDK4 signaling. [Abstract]

2023 Jan 1:312:121192. PMID: 36396113

Sodium dichloroacetate purchased from MedChemExpress. Usage Cited in: Life Sci. 2023 Jan 1:312:121192. [Abstract]

Sodium dichloroacetate (DCA; 10 mM; 48 h) significantly inhibits hypoxia-induced proliferation of HPASMCs (Fig I) , and markedly increases the apoptosis rate (Fig J).
Inflammation

Narciclasine Alleviates Endothelial Inflammation and Atherosclerosis Initiation by Inhibiting Histone Lactylation-Mediated NF-κB Activation. [Abstract]

2026 Jan 16;49(1):49. PMID: 41543766
Cancers (Basel)

Early Mechanisms of Chemoresistance in Retinoblastoma. [Abstract]

2022 Oct 10;14(19):4966. PMID: 36230889
J Biol Chem

Mitochondrial pyruvate carrier blockade results in decreased osteoclastogenesis and bone resorption via regulating mitochondrial energy production. [Abstract]

2022 Mar 4:101775. PMID: 35257748
Cell Signal

HOXA1 promotes aerobic glycolysis and cancer progression in cervical cancer. [Abstract]

2023 Sep:109:110747. PMID: 37286120
J Proteome Res

Regulating Energy Metabolism to Induce the Release of VOC Biomarkers in Lung Cancer Cells. [Abstract]

2025 Nov 7. PMID: 41201462
Exp Cell Res

Dichloroacetate enhances the anti-tumor effect of sorafenib via modulating the ROS-JNK-Mcl-1 pathway in liver cancer cells. [Abstract]

2021 Sep 1;406(1):112755. PMID: 34332981
J Trace Elem Med Biol

Sodium selenite inhibits proliferation of lung cancer cells by inhibiting NF-κB nuclear translocation and down-regulating PDK1 expression which is a key enzyme in energy metabolism expression. [Abstract]

2023 Jul:78:127147. PMID: 36963369
Mol Reprod Dev

Dysfunction in Sertoli cells participates in glucocorticoid-induced impairment of spermatogenesis. [Abstract]

2021 Jun;88(6):405-415. PMID: 34032349
bioRxiv

Citrate Compartmentalization Controls Calcium-Dependent Cytokine Production in Effector T Cells. [Abstract]

2026 Jun 12:2026.06.11.731694. PMID: 42327233
bioRxiv

2026 May 21.
Jacobs J Environ Sci

2025 Sep 12.
Oxid Med Cell Longev

NOX4-Derived ROS Mediates TGF- β 1-Induced Metabolic Reprogramming during Epithelial-Mesenchymal Transition through the PI3K/AKT/HIF-1 α Pathway in Glioblastoma. [Abstract]

2021 Jun 27;2021:5549047. PMID: 34257808
Oxid Med Cell Longev

α-Lipoic Acid Targeting PDK1/NRF2 Axis Contributes to the Apoptosis Effect of Lung Cancer Cells. [Abstract]

2021 Jun 4:2021:6633419. PMID: 34211631

Lösungsmittel & Löslichkeit

In Vitro:

H₂O : 100 mg/mL (662.60 mM; Need ultrasonic)

DMSO : 25 mg/mL (165.65 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

View the Complete Stock Solution Preparation Table

Preparing Stock Solutions

View the Complete Stock Solution Preparation Table

Concentration Solvent Mass

1 mg

5 mg

10 mg

Concentration

Solvent

Mass

1 mM

6.6260 mL

33.1301 mL

66.2603 mL

5 mM

1.3252 mL

6.6260 mL

13.2521 mL

10 mM

0.6626 mL

3.3130 mL

6.6260 mL

Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

In Vivo:

Working Solution

For the following dissolution methods, please prepare the working solution directly:

It is recommended to prepare fresh solutions and use them promptly within a short period of time.

The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: PBS

Solubility: 100 mg/mL (662.60 mM); Clear solution; Need ultrasonic

Reinheit & Dokumentation

Select Batch:

Reinheit: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (276 KB)
SDS (419 KB)
- English - EN (419 KB)
- Français - FR (419 KB)
- Deutsch - DE (419 KB)
- Norwegian - NO (419 KB)
- Español - ES (419 KB)
- Swedish - SV (419 KB)
- Italian - IT (419 KB)
- Portuguese - PT (419 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

Verweise

[1]. Stakišaitis D, et al. The Importance of Gender-Related Anticancer Research on Mitochondrial Regulator Sodium Dichloroacetate in Preclinical Studies In Vivo. Cancers (Basel). 2019 Aug 20;11(8). pii: E1210. [Content Brief]

[2]. Hossain M, et al. Cytotoxic derivatives of dichloroacetic acid and some metal complexes. Arch Pharm (Weinheim). 2022 Nov;355(11):e2200236. [Content Brief]

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg
DMSO / H₂O	1 mM	6.6260 mL	33.1301 mL	66.2603 mL	165.6507 mL
	5 mM	1.3252 mL	6.6260 mL	13.2521 mL	33.1301 mL
	10 mM	0.6626 mL	3.3130 mL	6.6260 mL	16.5651 mL
	15 mM	0.4417 mL	2.2087 mL	4.4174 mL	11.0434 mL
	20 mM	0.3313 mL	1.6565 mL	3.3130 mL	8.2825 mL
	25 mM	0.2650 mL	1.3252 mL	2.6504 mL	6.6260 mL
	30 mM	0.2209 mL	1.1043 mL	2.2087 mL	5.5217 mL
	40 mM	0.1657 mL	0.8283 mL	1.6565 mL	4.1413 mL
	50 mM	0.1325 mL	0.6626 mL	1.3252 mL	3.3130 mL
	60 mM	0.1104 mL	0.5522 mL	1.1043 mL	2.7608 mL
	80 mM	0.0828 mL	0.4141 mL	0.8283 mL	2.0706 mL
	100 mM	0.0663 mL	0.3313 mL	0.6626 mL	1.6565 mL

* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

Keywords

Sodium dichloroacetate

28 Cited Publications

100 mg Angebot einholen

Subscribe to the

MedChemExpress

Newsletter

Produktname:
Art. -Nr.:
Menge:
MCE Japan Authorized Agent:

Produktname:
CAS. Nr.:
Species:
Reinheit:
Menge:

Sodium dichloroacetate

MCE Bioactive Compound Library

Drug Repurposing Compound Library Plus

Clinical Compound Library Plus

Publications Citing Use of MedChemExpress (MCE) Sodium dichloroacetate

Biologische Aktivität

Chemical Information

Publications (28)

Lösungsmittel & Löslichkeit

Reinheit & Dokumentation

Verweise

Help & FAQs

Complete Stock Solution Preparation Table

Sodium dichloroacetate

MCE Bioactive Compound Library

Drug Repurposing Compound Library Plus

Clinical Compound Library Plus

Publications Citing Use of MedChemExpress (MCE) Sodium dichloroacetate

Biologische Aktivität

Chemical Information

Publications (28)

Lösungsmittel & Löslichkeit

Reinheit & Dokumentation

Verweise

Help & FAQs

Complete Stock Solution Preparation Table

Sodium dichloroacetate Related Classifications

Art. -Nr.: HY-Y0445A